PNEUMONIA
Clinical trials for PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new PNEUMONIA trials appear
Sign up with your email to follow new studies for PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug auxora studied in critically ill COVID-19 patients
Disease control TerminatedThis study tested a drug called Auxora in 10 people with severe COVID-19 pneumonia who needed a breathing machine. The goal was to see how the drug affected immune cells in the lungs and check for safety. The study was stopped early, so results are limited.
Matched conditions: PNEUMONIA
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New antibiotic tackles tough infections in vulnerable cancer patients
Disease control TerminatedThis study tested the antibiotic ceftolozane-tazobactam in 17 people with blood cancers or who had a stem cell transplant and developed a serious Pseudomonas infection. The goal was to see if the drug could help patients survive and clear the infection within 30 days. Participant…
Matched conditions: PNEUMONIA
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Smart band tracks COVID-19 breathing trouble
Knowledge-focused TerminatedThis study tested a special band called AirGo that monitors breathing in COVID-19 patients with respiratory failure. The goal was to see if the band could detect early signs of worsening breathing. The study included 25 adults hospitalized with COVID-19 who were breathing on thei…
Matched conditions: PNEUMONIA
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC